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ABSTRACT  
 
This paper reports for the first time on the natural 
history of diabetic retinopathy in three forms of youth 
onset diabetes seen in our country based on a 4 year 
follow-up study. Forty patients each with Fibro-
calculous Pancreatic Diabetes (FCPD), Maturity 
Onset Diabetes of Youth (MODY) and Insulin-De-
pendent Diabetes Mellitus (IDDM) were followed for 
periods up to four years with annual fundus colour 
photography using an international retinal grading 
system. All patients had early background diabetic 
retinopathy at the onset of the study. The rate of pro-
gression of retinopathy was found to be similar in all 
three study groups. The study proves that patients 
with secondary forms, of diabetes (FCPD) also de-
velop retinopathy at the same rate as primary forms of 
diabetes. Moreover, it disproves earlier studies that 
patients with MODY are protected from retinopathy.  
 
Diabetic retinopathy is the leading cause of blindness 
in all developed countries [1]. There is very little data 
on diabetic retinopathy from developing countries. In 
South India, there are some unique forms of diabetes 
that are extremely rare in Western countries. Fibro-
calculous Pancreatic Diabetes (FCPD) is a type of 
diabetes that is secondary to Tropical Calcific 
Pancreatitis (TCP) [2]. The highest known prevalence 
of FCPD in the world is in Southern India [3]. 
Maturity Onset Diabetes of Youth (MODY) is a form 
of Non-Insulin-Dependent Diabetes Mellitus 
characterized by autosomal dominant inheritance and 
onset in youth. We [4] and others [5] have shown that 
MODY is highly prevalent among Indians. 
 
It was earlier believed that retinopathy was rare in 
FCPD [2] and in MODY subjects [6]. We have docu-
mented in earlier studies that retinopathy does occur 
in FCPD [7] and in MODY patients [4]. However 
both these studies were cross-sectional in nature and 
there is virtually no longitudinal studies on the natural 
history of diabetic retinopathy in our country. 
 
In this study we present a four year follow-up study 
of diabetic retinopathy in FCPD and MODY patients 
and compare the results with a group of Insulin-De-
pendent Diabetes Mellitus (IDDM) patients. Our aim 
was to study patients of similar age group, namely 
FCPD, MODY and IDDM, all of which present at a 
younger age. For this reason, classical NIDDM which 
usually develops at a later age, was not included in 
this study. 
 
PATIENTS AND METHODS 
 
The criteria for diagnosis of diabetes was based on 
WHO Study Group criteria [8]. The criteria for diag-
nosis of FCPD, MODY and IDDM are given below:  
 
FCPD 
 
Diabetic patients classified under this group gave 
usually a history of recurrent abdominal pain from 
childhood and had uniequivocal evidence of pancre-
atic calculi on a plain abdominal roentgenogram 
and/or other features of chronic pancreatitis according 
to the criteria of Mohan [9J. In every patient other 
causes of chronic pancreatitis (eg. alcoholism) were 
excluded. 
 
MODY The criteria of Tattersal and Fajans [10] were 
used for diagnosis of MODY namely: 
 
a. Age at diagnosis of diabetes less than 25 years.  
b. Control of fasting hyperglycaemia for a minimum 
  period of 2 years without insulin. 
c. Absence of ketosis at any time.  
d. Autosomal dominant inheritance. 
 
IDDM Patients classified under this group had abrupt 
onset of symptoms, were prone to ketosis in the basal 
state, had evidence of ketoacidosis in the past and 
were consistently on insulin therapy, either from the 
time of diagnosis or shortly thereafter. Additionally, 
all patients had fasting plasma C-pepfide < 0.1 pmol/ 
ml and stimulated levels < 0.2 pmol/ml. 
 
Inclusion Criteria 
 
Only patients who had minimal background diabetic 
retinopathy (with few scattered microaneurysms) cor-
responding to level 21 of the internationally accepted 
Early Treatment Diabetes Retinopathy Study 
(ETDRS) adaptation of the Wisconsin grading system 
of retinopathy [11] were included in the study. 
Patients with nephropathy, cardiac disease, 
hypertension or systemic diseases were excluded 
from the study. 
 
Clinical and Biochemical Studies 
 
Baseline studies included a complete physical ex-
amination  including  height,  weight  and  body  mass  
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index. Fasting and post-prandial plasma glucose es-
timations by glucose oxidase method, serum cho-
lesterol by CHOD-PAP method and triglycerides by 
GOP-PAP method, blood urea by modified Berthelot 
method and serum creatinine by modified kinetic 
method of Jaffe were done in all patients using 
Corning Express Plus Autoanalyser (Corning, USA). 
Plain roentgenogram of chest and abdomen, ECG and 
doppler studies were also done in all cases.  
 
Ophthalmic Studies 
 
At baseline, all patients underwent a complete oph-
thalmic examination including visual acuity testing 
(with pin hole), slit lamp, anterior segment examina-
tion and ocular pressure studies. A detailed retinal 
examination was done using direct and indirect 
ophthalmoscopy. A seven field stereoscopic colour 
photography was done in all cases and the retinopathy 
was graded using the ETDRS adaptation of the 
Wisconsin grading system [11]. The grading was 
done in a 'blinded' manner so that the grader was 
unaware of whose photograph was being graded. 
Grading was done by an ophthalmologist (M. Rema) 
who had experience in grading previous international 
studies. 
 
ETDRS Classification of Retinopathy 
 
Level 10 : No retinopathy 
Level 21-31 : Minimal to mild non-proliferative 
retlnopathy   
Level 41-51 : Moderate to severe non-proliferative 
retinopathy 
Level 60 : Fibrous proliferations only  
Level 65 : Early proliferative changes 
Level 70-80 : Proliferative retinopathy with Diabetic 
Retinopathy Study high risk characteristics for severe 
visual loss or the most severe retinopathy leading to 
ungradable eyes because of vitreous haemorrhage or 
other complications of diabetic retinopathy.  
 
Retinopathy levels for each individual was derived by 
giving the eye with the higher level (more severe 
retinopathy) greater weight. 'Progression' of 
retinopathy was considered to have occurred if the 
retinopathy showed a worsening by atleast 2 levels. 
 
Follow-up 
 
Patients were seen annually and all clinical and bio-
chemical tests were repeated at yearly intervals. 
Retinal colour photography was done in all cases on 
an annual basis and the retinopathy was graded again. 
The period of follow-up was upto 4 years. 
 
RESULTS 
Table 1 outlines the clinical characteristics of the 
three study groups at the onset of the study (baseline). 
It can be seen that there were no significant 
differences in age, sex, duration of diabetes or blood 
pressure between groups. The mean body mass index 
was lower in the FCPD and IDDM groups compared 
to the MODY group. 
Table 1 
Clinical Characteristics of Study Groups at 
Baseline (Onset of Study) 
 
           P Value Significance 
 
Parameter          FCPD      MODY     IDDM      FCPD      FCPD     IDDM 
           n = 40     n = 40       n =40        vs            vs           vs 
                         MODY    MODY    MODY 
 
Sex Ratio M:F      25:15     24:16       22:18 
 
Age (Yrs)             40±19     39±7       38±12       NS           NS         NS 
 
Duration of  
Diabetes (Yrs)       13±5     15±6        14±6        NS            NS        NS 
 
Body Mass 
Index (BMI)     19.3±2.4   24.2±3.4  2.3±2.9  P<0.001  P=0.003  P<0.001 
(kg/m2) 
 
Systolic BP 
(mm Hg)          125±17    125±21     117±17      NS         NS          NS 
 
Diastolic BP 
(mm Hg)         81±2         80±1         75±9        NS        NS          NS 
 
FCPD - Fibro-calculous Pancreatic Diabetes  
MODY - Maturity Onset Diabetes of Youth  
IDDM - Insulin-Dependent Diabetes Mellitus  
NS - Not Significant 
Table 2 details the baseline biochemical character-
istics between the three groups (P < 0.001 ). There 
was no significant difference in the fasting or post-
prandial plasma glucose, glycosylated haemoglobin 
or triglyceride levels between the three groups. The 
serum cholesterol levels were lower in the FCPD 
group compared to other two groups (P < 0.001 vs 
MODY, P < 0.003 vs IDDM). 
Table 2 
Biochemical Characteristics of Study Groups (at 
baseline) 
 
                Significance 
 
Parameter          FCPD      MODY     IDDM      FCPD      FCPD     IDDM 
           n = 40     n = 40       n =40        vs            vs           vs 
                         MODY    MODY    MODY 
 
Fasting Plasma 
Glucose (mg/dl)  207±76   223±79   206±93      NS          NS        NS 
 
Glycosylated   
Haemoglobin     10.7±1.6  10.4±1.2 10.4±1.5     NS         NS       NS 
(%) 
 
Serum  
Creatinine           0.8±0.3    0.7±0.1   0.7±0.2      NS          NS        NS 
 
Seum 
Cholesterol        182±30    217±30    214±48  P<0.001  P=0.002   NS   
(mg/dl) 
 
Serum 
Tryglycerides     126±98     126±86  130±81      NS         NS         NS 
(mg/dl) 
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Table 3 shows the follow-up biochemical parameters 
at the end of the study. There is no significant differ-
ence between the three groups with respect to fasting 
plasma glucose levels or glycosylated haemoglobin 
levels. However, in all three groups the fasting 
plasma glucose and glycosylated haemoglobin levels 
showed significant improvement during the study and 
the mean value decreased from 10.5% to 9%. 
Table 3 
Biochemical Parameters at End of Study 
in Three Groups 
 
               Significance 
 
Parameter          FCPD      MODY     IDDM      FCPD      FCPD     IDDM 
           n = 40     n = 40       n =40        vs            vs           vs 
                         MODY    MODY    MODY 
 
Fasting plasma  
Glucose(mg/dl)  156±49    140±40  166±50      NS          NS          NS 
 
Glycosylated 
Haemoglobin     9.5±2.0   9.1±1.8    9.8±2.0      NS          NS NS   
 
 
Table 4 shows the results of the progression of dia-
betic retinopathy in the three groups. Follow-up data 
was available in 32 FCPD, 23 MODY and 34 IDDM 
patients. The results showed that 21/32 FCPD patients 
(65.5%), 14/23 MODY patients (60.8%) and 21/34 
IDDM patients (61.7%) showed progression of the 
diabetic retinopathy. Figure 1 shows the results in a 
graphical form. 
Table 4 
Progression of Diabetic Retinopathy 
in the Three Groups 
 
   Progression of Retinopathy 
 
  FCPD  21  11  
  n = 32 (65.6%) (34.4%)   
 
  MODY  14  9  
  n = 23 (60.8%) (39.2%)   
 
  IDDM  1 3  21  
  n = 34 (61.7%) (38.3%)   
 
Chi Square test = 0.6, N.S.   
FCPD - Fibro-calculous Pancreatic Diabetes  
 MODY - Maturity Onset Diabetes of Youth 
 IDDM - Insulin-Dependent Diabetes Mellitus 
 
 
Table 5 shows the mean period of follow-up in the 
three groups studied. There was no significant dif-
ference in the period of follow-up between those with 
and without progression of the retinopathy. 
 
Table 5 
Mean Duration of Follow-up .(Years)  
 
Forms     Groups with     Groups without     P-Value 
    Progression     Progression 
 
FCPD             2.9±0.9           2.6±0.2               NS  
 
MODY           2.8±1.5           2.3±1.1               NS  
 
IDDM             2.5±0.7           2.1±0.8               NS 
 
FCPD - Fibro-calculous Pancreatic Diabetes  
MODY - Maturity Onset Diabetes of Youth  
IDDM - Insulin-Dependent Diabetes Mellitus  
NS - Not Signiticant 
 
DISCUSSION 
 
The study provides data for the first time on the natu-
ral history of diabetic retinopathy in three groups of 
young diabetics seen in South India namely FCPD, 
MODY and IDDM. There is virtually no data in exist-
ing literature on the natural history of retinopathy in 
FCPD and MODY as both entities are rare in Euro-
pean populations. 
 
Earlier studies had suggested that being a secondary 
form of diabetes, FCPD patients do not develop 
diabetic retinopathy. This was stated in Geevarghese's 
earlier monogram on Pancreatic Diabetes published in 
1968 [2]. In 1985, in his second monogram [3], 
Geevarghese revised his view and stated that 
retinopathy does occur in FCPD. It is noteworthy that 
he had a chapter on retinopathy in this volume. This 
change in view point was obviously based on the 
longer follow-up of his patients. In our study 
published in 1985 [7] we showed for the first time 
that not only do FCPD patients develop retinopathy 
but that they also develop sight threatening forms of 
the disease. 
 
There is no longitudinal follow-up data on the natural 
history of diabetic retinopathy in FCPD as both 
Geevarghese's [3] as well as our earlier study [7] were 
cross sectional in nature. In this unique followup 
study using internationally accepted methodology we 
provide evidence that progression of retinopathy does 
occur in FCPD patients and that the rate of pro-
gression is the same as in the two other groups of 
diabetics, namely MODY and IDDM. Thus patients 
with FCPD, a secondary form of diabetes, appear to 
be as prone to microvascular complications of dia-
betics, as those with primary forms of diabetes.  
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The data on MODY is also of great interest. The oc-
currence of retinopathy in MODY is still an unsettled 
issue. While Tattersal [5] maintains that retinopathy 
does not occur in MODY, Fajans [12) has shown that 
it does occur. Our present study supports the latter's 
view that subjects with MODY not only develop 
retinopathy but also have a rate of progression that is 
similar to IDDM patients. 
 
We are unable to find any specific reasons for pro-
gression or lack of progression of retinopathy from 
our study. it is clear that the control of diabetes was 
not optimum in any of our patient groups although 
there was a decrease in the mean glycosylated hae-
moglobin at the end of the study. This could explain 
the reason why over 60% of patients in all three 
groups showed some degree of progression. However 
there were no significant differences between this 
60% and the 40% who did not progress, either in the 
clinical or biochemical parameters. 
 
This raises the question of a genetic susceptibility to 
retinopathy. In a recent study, we showed that there is 
a genetic susceptibility to the development of pro-
liferative diabetic retinopathy [13]. It is likely that this 
is not a chance finding, because study numbers were 
large and moreover another study from the UK [14] 
had also shown similar findings. If these findings are 
confirmed by our presently ongoing studies, it will 
help to explain the paradox often seen in clinical prac-
tice of some patients with good control developing 
retinopathy and others with poor control who never 
develop retinopathy. 
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